Suri Venkatachalam, Founder and CEO, Connexios Life Sciences

Suri Venkatachalam
Founder and CEO
Connexios Life Sciences

Suri Venkatachalam is the founder and currently serves as the CEO of Connexios Life Sciences Pvt. Ltd. Connexios is a Bangalore based pharmaceutical company that leverages a unique translational network biology approach to disease biology to discover and develop novel therapeutics for unmet clinical needs in the area of diabetes and diseases of metabolism. Suri helped architect the translational network biology platform and is currently responsible for the science and business strategy at Connexios. Suri is also one of the founding directors of Group Lifespring, a human health focused group of companies (including Connexios) spanning from discovery to health care that is supported by Nadathur Holdings and Investments. He is also a co-founder of Achira Labs, a Bangalore based start¬up developing a diagnostics technology platform based on a unique microfluidics based approach.

Before founding Connexios in 2003, Suri was part of the founding team of Metahelix Life Sciences Pvt. Ltd. an Agri-biotech company based in Bangalore. Before, his move to industry, Suri was a Research Associate in Indian Institute of Science, Bangalore; a visiting scientist at the computer science department of Linkoping University, Sweden, an adjunct associate fellow at the National Institute of Advanced Studies, Bangalore and a LJIS Burroughs-Wellcome post doctoral fellow in computational neuroscience at the University of California, San Diego. Suri holds a Bachelors degree in Chemical Engineering and a PhD in condensed matter physics from the Indian Institute of Science.